SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $196,880 | -98.4% | 4,000 | -98.8% | 0.00% | -98.2% |
| Q4 2023 | $12,333,350 | +268.6% | 337,900 | +159.9% | 0.17% | +155.4% |
| Q1 2023 | $3,346,200 | -66.1% | 130,000 | -65.8% | 0.06% | -57.8% |
| Q4 2022 | $9,883,800 | +87.8% | 380,000 | +106.0% | 0.15% | +111.0% |
| Q3 2022 | $5,264,000 | +4642.3% | 184,500 | +4006.4% | 0.07% | +3550.0% |
| Q2 2022 | $111,000 | -98.8% | 4,493 | -97.3% | 0.00% | -98.2% |
| Q1 2022 | $9,323,000 | – | 165,180 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |